D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Qualcomm
QCOM
|
+$555M |
| 2 |
Marathon Petroleum
MPC
|
+$538M |
| 3 |
Ford
F
|
+$529M |
| 4 |
Walmart
WMT
|
+$508M |
| 5 |
Apple
AAPL
|
+$499M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$716M |
| 2 |
Merck
MRK
|
+$498M |
| 3 |
Meta Platforms (Facebook)
META
|
+$425M |
| 4 |
McDonald's
MCD
|
+$369M |
| 5 |
Wells Fargo
WFC
|
+$362M |
Sector Composition
| 1 | Technology | 20.88% |
| 2 | Consumer Discretionary | 13.12% |
| 3 | Healthcare | 9.93% |
| 4 | Communication Services | 9.58% |
| 5 | Financials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVAN
926
DELISTED
Avanti Acquisition Corp.
AVAN
| $10M | 0.01% |
1,026,694
+848,134
| +475% | +$8.26M |
|
|
GIWWU
927
DELISTED
GigInternational1, Inc. Units
GIWWU
| $10M | 0.01% |
+990,000
| New | +$10M |
|
928
Tyson Foods
TSN
$19.8B
| $9.99M | 0.01% |
135,453
-68,342
| -34% | -$5.04M |
|
929
Murphy USA
MUSA
$7.56B
| $9.99M | 0.01% |
74,861
-191,562
| -72% | -$25.6M |
|
|
DISAU
930
DELISTED
Disruptive Acquisition Corporation I Unit
DISAU
| $9.97M | 0.01% |
1,000,000
| – | – |
|
931
Philip Morris
PM
$261B
| $9.93M | 0.01% |
100,177
+92,555
| +1,214% | +$9.17M |
|
932
Prestige Consumer Healthcare
PBH
$3.18B
| $9.88M | 0.01% |
189,697
-88,807
| -32% | -$4.63M |
|
|
EXEEZ
933
Expand Energy Corporation Class B Warrants
EXEEZ
| $9.87M | 0.01% |
414,245
| – | – |
|
934
Magna International
MGA
$13B
| $9.87M | 0.01% |
106,566
-120,439
| -53% | -$11.1M |
|
935
Pacira BioSciences
PCRX
$1.23B
| $9.86M | 0.01% |
162,523
-436,006
| -73% | -$26.5M |
|
936
Dayforce
DAY
$10.9B
| $9.86M | 0.01% |
102,777
-71,185
| -41% | -$6.83M |
|
|
AGR
937
DELISTED
Avangrid, Inc.
AGR
| $9.85M | 0.01% |
191,587
+59,846
| +45% | +$3.08M |
|
938
Quanta Services
PWR
$57.9B
| $9.81M | 0.01% |
108,262
+43,658
| +68% | +$3.95M |
|
939
Healthpeak Properties
DOC
$12.6B
| $9.78M | 0.01% |
293,871
-107,496
| -27% | -$3.58M |
|
940
Cimpress
CMPR
$1.47B
| $9.76M | 0.01% |
90,002
-19,127
| -18% | -$2.07M |
|
941
TrueCar
TRUE
$210M
| $9.75M | 0.01% |
1,725,949
-294,304
| -15% | -$1.66M |
|
942
Arcus Biosciences
RCUS
$1.24B
| $9.75M | 0.01% |
354,946
-204,363
| -37% | -$5.61M |
|
943
Ocular Therapeutix
OCUL
$2.24B
| $9.74M | 0.01% |
687,180
+35,052
| +5% | +$497K |
|
944
Mohawk Industries
MHK
$8.56B
| $9.73M | 0.01% |
+50,623
| New | +$9.73M |
|
945
FIVE9
FIVN
$2.03B
| $9.72M | 0.01% |
53,017
+25,082
| +90% | +$4.6M |
|
946
FS KKR Capital
FSK
$4.96B
| $9.72M | 0.01% |
452,018
+314,831
| +229% | +$6.77M |
|
|
SWBK
947
DELISTED
Switchback II Corporation
SWBK
| $9.66M | 0.01% |
976,306
+851,306
| +681% | +$8.42M |
|
948
Advent Technologies
ADN
$8.06M
| $9.64M | 0.01% |
33,333
| – | – |
|
949
Cheesecake Factory
CAKE
$2.86B
| $9.64M | 0.01% |
177,845
+141,427
| +388% | +$7.66M |
|
950
GrafTech
EAF
$246M
| $9.59M | 0.01% |
82,484
+36,012
| +77% | +$4.18M |
|